Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
BMC Cancer|October 22, 2015
Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecanSeung Tae Kim, Tae Jin Ahn, Eunjin Lee, et al.
Molecular Cancer Research : MCR|June 20, 2020
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast CancerSehhoon Park, Eunjin Lee, Seri Park, et al.
Cancer Research and Treatment|October 4, 2021
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung CancerShinkyo Yoon, Hannah Yang, Hyun-Min Ryu, et al.
Scientific Reports|June 25, 2016
Gene Expression Profiling of Breast Cancer Brain MetastasisJi Yun Lee, Kyunghee Park, Eunjin Lee, et al.
Cellular and Molecular Life Sciences : CMLS|August 20, 2025
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesHyun-Min Ryu, Deokhoon Kim, Jun Young Choi, et al.
Cancer Research and Treatment|February 25, 2016
Association between Mutation and Expression of <i>TP53</i> as a Potential Prognostic Marker of Triple-Negative Breast CancerJi-Yeon Kim, Kyunghee Park, Hae Hyun Jung, et al.
Frontiers in Nutrition|December 5, 2024
Post-harvest processed parsnip showed improved anti-oxidative capacity and protective potential against acrolein-induced inflammation <i>in vitro</i> and <i>in vivo</i>Kangwook Lee, Jeong Hoon Pan, La Yoon Choi, et al.
American Journal of Cancer Research|October 12, 2020
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancerJunyoung Choi, Hee Jin Lee, Shinkyo Yoon, et al.
Journal of Medical Internet Research|June 19, 2025
Large Language Model-Assisted Surgical Consent Forms in Non-English Language: Content Analysis and Readability EvaluationNamkee Oh, Jongman Kim, Sunghae Park, et al.
Cancer Research|May 6, 2025
Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer CellsSoyoung Lee, Kyunghwan Kim, Hye-Jin Jeong, et al.
Pageof 12